Sonoma Pharmaceuticals (SNOA) Tops Q3 EPS by 6c

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.63), $0.06 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• CACI wins U.S. Space Force contract worth up to $981M
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance